The Osteopathic Medical Board of California convened on November 14, 2024, to discuss significant regulatory updates and the establishment of new committees aimed at enhancing board operations. The meeting highlighted the progress on a long-awaited Continuing Medical Education (CME) regulatory package, which has been in development since 2018. The board announced that the package has been approved for public comment, marking a crucial step towards implementation.

During the meeting, board members expressed optimism about the expedited approval process, noting that the quality of the regulatory language has improved significantly. The CME package, which includes updates on audits and self-renewals, is expected to streamline operations for both staff and licensees. The board anticipates that if the package receives approval from the Office of Administrative Law, it could be implemented as early as April 2025.

In addition to the CME updates, the board established several committees, including executive, legislative, licensing, enforcement, and education and outreach committees. This move aims to enhance engagement and oversight on key issues, reflecting a more collaborative approach among board members.

Public comments during the meeting were minimal, with one participant expressing support for the board's initiatives and offering assistance in ongoing regulatory efforts. The board also discussed future agenda items, including updates on the transition of a diversion program and the potential inclusion of a student or resident board member to foster engagement with future healthcare professionals.

Overall, the meeting underscored the board's commitment to improving regulatory processes and enhancing the efficiency of its operations, with a focus on timely implementation of necessary changes. The next meeting is tentatively scheduled for January 30, 2025, pending confirmation of member availability.